🇫🇷France’s clinical research faces challenges: admin delays, limited funding, and gender gaps hinder progress in anaesthesia & intensive care. Boosting support for all healthcare staff is vital to drive innovation and improve patient care!
🔗https://t.co/WX2cjj7DPy
New drugs for acute kidney injury
CCR Journal Watch
https://t.co/Sp06oA6IDG
Get the latest critical care literature every weekend via the CCR Newsletter - subscribe at https://t.co/nitMzacLrj
Adults undergoing cardiac surgery with cardiopulmonary bypass received either an intravenous balanced mixture of amino acids or placebo for up to 3 days. Amino acids reduced the occurrence of acute kidney injury. Full PROTECTION trial results: https://t.co/fPNrcChpm6
#CCR24
Presented at #HeartFailure2024:
Among patients with symptomatic obstructive hypertrophic cardiomyopathy, treatment with aficamten led to a greater increase in peak oxygen consumption than placebo at 6 months. Full SEQUOIA-HCM phase 3 trial results: https://t.co/8M0wEtJ96d
Just published in @JCVAonline: Peri-operative risk factor associated with #AKI after #Heart transplantation #HTx
⬆️BMI
🕐cold ischemia duration
➡️Level of intra-operative dobutamine
⚠️At one year, #AKI impact mortality after #Heart transplantation
https://t.co/AdEaW4diao
Capillary refill time in shock as relevant monitoring tool in septic shock
⚙️ technical considerations
👉🏻 CRT monitoring & clinical outcomes
🎯 CRT as resuscitation target
🩸 kinetics of CRT (rapid) response to acute hemodynamic interventions
#FOAMcc
🔓 https://t.co/A4byJTRguO
Delighted to share our latest work on #ECMO management
➡️CRT and fluid responsiveness during VA-ECMO
Capillary refill time assessment after fluid challenge in patients on ... https://t.co/XiYwFxyvXg
Delighted to share our work just published in @Crit_Care on prevention of cardiac surgery associated acute kidney injury #CSA#AKI
✅️ GDP
✅️ RIPc
https://t.co/jExN4Zmper
🆕️⚡️⚡️@Crit_Care with @MarcLeone8
In this ancillary study of the iDIAPASON trial, the use of combination therapy Vs monotherapy was not associated with a difference in mortality or Pseudomonas aeruginosa VAP recurrence in ICU at day 90 #IDTwitter
https://t.co/PRzLDiQsgh